Sonic hedgehog antagonists induce cell death in acute myeloid leukemia cells with the presence of lipopolysaccharides, tumor necrosis factor-α, or interferons

Frank Leigh Lu, Ching Chia Yu, Huei Hsuan Chiu, Hsingjin Eugene Liu, Shao Yin Chen, Shufan Lin, Ting Yi Goh, Hsin Chih Hsu, Chih Han Chien, Han Chung Wu, Ming Shan Chen, Scott C. Schuyler, Wu Shiun Hsieh, Mei Hwan Wu, Jean Lu

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Summary: Due to the development of drug resistance, the outcome for the majority of patients with acute myeloid leukemia (acute myelogenous leukemia; AML) remains poor. To prevent drug resistance and increase the therapeutic efficacy of treating AML, the development of new combinatory drug therapies is necessary. Sonic hedgehog (Shh) is expressed in AML biopsies and is essential for the drug resistance of cancer stem cells of AML. AML patients are frequently infected by bacteria and exposed to lipopolysaccharide (LPS). LPS itself, its derivatives, and its downstream effectors, such as tumor necrosis factor-α (TNF-α) and interferons (IFNs), have been shown to provoke anti-tumor effects. The application of a Shh inhibitor against AML cells in the presence of LPS/TNF-α/IFNs has not been investigated. We found that the Shh inhibitor cyclopamine in combination with LPS treatment synergistically induced massive cell apoptosis in THP-1 and U937 cells. The cytotoxic effects of this combined drug treatment were confirmed in 5 additional AML cell lines, in primary AML cells, and in an AML mouse model. Replacing cyclopamine with another Shh inhibitor, Sant-1, had the same effect. LPS could be substituted by TNF-α or IFNs to induce AML cell death in combination with cyclopamine. Our results suggest a potential strategy for the development of new therapies employing Shh antagonists in the presence of LPS/TNF-α/IFNs for the treatment of AML patients.

Original languageEnglish
Pages (from-to)823-832
Number of pages10
JournalInvestigational New Drugs
Volume31
Issue number4
DOIs
Publication statusPublished - Aug 2013

Keywords

  • Acute myeloid leukemia
  • Cyclopamine
  • Interferon
  • Lipopolysaccharides
  • Sant-1
  • Sonic hedgehog
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Oncology

Fingerprint Dive into the research topics of 'Sonic hedgehog antagonists induce cell death in acute myeloid leukemia cells with the presence of lipopolysaccharides, tumor necrosis factor-α, or interferons'. Together they form a unique fingerprint.

  • Cite this

    Lu, F. L., Yu, C. C., Chiu, H. H., Liu, H. E., Chen, S. Y., Lin, S., Goh, T. Y., Hsu, H. C., Chien, C. H., Wu, H. C., Chen, M. S., Schuyler, S. C., Hsieh, W. S., Wu, M. H., & Lu, J. (2013). Sonic hedgehog antagonists induce cell death in acute myeloid leukemia cells with the presence of lipopolysaccharides, tumor necrosis factor-α, or interferons. Investigational New Drugs, 31(4), 823-832. https://doi.org/10.1007/s10637-012-9908-5